ProfileGDS2971 / 12.3.3.21
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 44% 50% 54% 56% 84% 74% 70% 33% 52% 33% 43% 34% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.043900744
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)0.063487850
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 20.064648554
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)0.10014156
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)0.60605284
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.34537374
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.35543770
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-0.26636833
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)0.069614552
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.23409133
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)-0.067211143
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.17929934